Loading…
RadNet, Inc., together with its subsidiaries, provides outpatient diagnostic imaging services in the United States and internationally. The company operates in two segments, Imaging Centers and Digital Health. Its services include magnetic resonance imaging, computed tomography, positron emission tomography, nuclear medicine, mammography, ultrasound, diagnostic radiology, fluoroscopy, and other related procedures, as well as multi-modality imaging services. The company also develops and sells computerized systems that distribute, display, store, and retrieve digital images; picture archiving communications systems and related services; and develops and deploys AI suites to enhance radiologist interpretations of breast, lung, and prostate images, as well as solutions for prostate cancer screening. In addition, it develops and delivers AI-powered health informatics solutions to drive quality, efficiency, and outcomes in imaging and radiology; informatics designed for outpatient radiology; and DeepHealth OS, a cloud-native operating system that helps in the operations of the radiology service. RadNet, Inc. was founded in 1981 and is headquartered in Los Angeles, California.
5-year financial trends. Figures in USD millions.
Latest fiscal year: 2025
Year-by-year revenue, profitability, and cash flow (USD millions, last 10 years)
| Year | Revenue | EBITDA | Net Profit | FCF | ROE | Rev Growth 1Y | NP Growth 1Y |
|---|---|---|---|---|---|---|---|
| 2025 | $2.0B | $314M | $-19M | $86M | -1.7% | 11.5% | -767.8% |
| 2024 | $1.8B | $323M | $3M | $45M | 0.3% | 13.2% | -8.2% |
| 2023 | $1.6B | $293M | $3M | $44M | 0.5% | 13.0% | -71.4% |
| 2022 | $1.4B | $279M | $11M | $27M | 3.2% | - | - |
| 2021 | - | - | - |
Income statement, balance sheet, and cash flow as reported
Consolidated Figures in USD Millions.
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total Revenue | - | 1,430.06 | 1,616.63 | 1,829.66 | 2,040.21 |
| Cost Of Revenue | - | 1,264.35 | 1,395.24 | 1,580.55 | 1,804.72 |
| Gross Profit | - | 165.72 | 221.39 | 249.12 | 235.48 |
| Operating Expense | - | 115.88 | 128.39 | 137.84 | 152.13 |
| Operating Income | - | 49.84 | 93 | 111.28 | 83.36 |
| EBITDA | - | 278.53 | 292.79 | 323.10 | 313.82 |
| EBIT | - | 93.81 | 103.29 | 124.71 | 101.82 |
| Pretax Income | - | 42.97 | 38.81 | 44.86 | 31.91 |
| Tax Provision | - | 9.36 | 8.47 | 6.03 | 14.86 |
| Net Income | - | 10.65 | 3.04 | 2.79 | -18.65 |
| Net Income Common Stockholders | - | 10.65 | 3.04 | 2.79 | -18.65 |
| Total Expenses | - | 1,380.22 | 1,523.63 | 1,718.39 | 1,956.85 |
| Interest Expense | - | 50.84 | 64.48 | 79.85 | 69.91 |
| Normalized EBITDA | - | 243.12 | 312.08 | 349.06 | 342.29 |
| Normalized Income | - | -17.05 | 18.13 | 25.26 | 3.85 |
| Market Cap | 4,510.79 | 4,510.79 | 4,510.79 | 4,510.79 | 4,510.79 |
Healthcare sector peers, ranked by market cap
| Company | Ticker | Market Cap | P/E | P/B | ROE | EV/EBITDA |
|---|---|---|---|---|---|---|
| RadNet, Inc.this co. | RDNT | - | -241.84 | 4.14 | -1.7% | 17.85 |
| Integer Holdings Corporation | ITGR | $3.0B | 28.79 | 1.69 | 5.9% | 14.55 |
| Organon & Co. | OGN | $2.9B | 15.67 | 3.90 | 24.9% | 8.53 |
| Prestige Consumer Healthcare Inc. | PBH | $2.9B | 13.00 | 1.52 | 11.7% | 10.32 |
| Privia Health Group, Inc. | PRVA | $2.9B | 130.67 |
| - |
| - |
| - |
| - |
| 4.06 |
| 3.1% |
| 57.20 |
| Veracyte, Inc. | VCYT | $2.7B | 41.28 | 2.09 | 5.1% | 26.96 |
| National HealthCare Corporation | NHC | $2.7B | 22.47 | 2.52 | 11.2% | 12.59 |
| LeMaitre Vascular, Inc. | LMAT | $2.6B | 44.90 | 6.59 | 14.7% | 30.28 |
| Phibro Animal Health Corporation | PAHC | $2.2B | 46.33 | 7.83 | 16.9% | 19.95 |
| Peer Median | - | 35.04 | 3.21 | 11.5% | 17.25 | |